# Lexaria Bioscience Corp.: funding, 10-K (November 2026)

Registers read on November 19, 2026.

Lexaria Bioscience Corp. (British Columbia, Canada) appears in 2 public registers SpecStream reads: 15 Form D filings and 5 SEC annual and quarterly reports; the newest record is dated September 21, 2026, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 2
- Newest record: September 21, 2026
- Country: British Columbia, Canada

## Form D filings (SEC)

15 Form D filings, newest September 21, 2026.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/lexaria-bioscience-corp-1348362) | September 21, 2026 | $113.5 thousand sold of $113.5 thousand offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348362/000134836226000002/0001348362-26-000002-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/lexaria-bioscience-corp-1348362) | December 19, 2025 | $3.5 million sold of $3.5 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348362/000134836225000018/0001348362-25-000018-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/lexaria-bioscience-corp-1348362) | October 1, 2025 | $4 million sold of $4 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348362/000134836225000017/0001348362-25-000017-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/lexaria-bioscience-corp-1348362) | October 16, 2024 | $5 million sold of $5 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348362/000134836224000005/0001348362-24-000005-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/lexaria-bioscience-corp-1348362) | May 2, 2024 | $364.6 thousand sold of $364.6 thousand offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348362/000185576324000003/0001855763-24-000003-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/lexaria-bioscience-corp-1348362) | February 16, 2024 | $3.6 million sold of $3.6 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348362/000185576324000001/0001855763-24-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/lexaria-bioscience-corp-1348362) | October 4, 2023 | $1.6 million sold of $1.6 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348362/000185576323000006/0001855763-23-000006-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/lexaria-bioscience-corp-1348362) | December 20, 2021 | $1.2 million sold of $1.2 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348362/000134836221000002/0001348362-21-000002-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/lexaria-bioscience-corp-1348362) | July 27, 2021 | $85 thousand sold of $85 thousand offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348362/000134836221000001/0001348362-21-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/lexaria-bioscience-corp-1348362) | July 8, 2020 | $100 thousand sold of $100 thousand offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348362/000134836220000007/0001348362-20-000007-index.htm) |

- [Lexaria Bioscience Corp.](https://specstream.ai/data/form-d/company/lexaria-bioscience-corp-1348362)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1348362&type=D)

## Public company financials (SEC)

5 SEC annual and quarterly reports, newest November 28, 2025.

- SEC central index key (CIK): 1348362
- Industry: SIC 2834, Pharmaceutical preparations
- Filer category: Non-accelerated filer

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [10-K filed November 28, 2025](https://specstream.ai/data/public-companies/company/1348362-lexaria-bioscience-corp) | November 28, 2025 | Revenue $705.9 thousand | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348362/000164033425002225/0001640334-25-002225-index.htm) |

- [Lexaria Bioscience Corp.](https://specstream.ai/data/public-companies/company/1348362-lexaria-bioscience-corp)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (British Columbia, Canada), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Beverage suppliers in the United States](https://specstream.ai/data/businesses/beverage-suppliers/united-states)
- [Siding contractors in the United States](https://specstream.ai/data/businesses/siding-contractors/united-states)
- [Italian restaurants in the United States](https://specstream.ai/data/businesses/italian-restaurants/united-states)
- [Commercial printers in the United States](https://specstream.ai/data/businesses/commercial-printers/united-states)
- [Truck and industrial vehicle companies in the United States](https://specstream.ai/data/businesses/truck-and-industrial-vehicle-companies/united-states)
